Organigram Global Inc.

Healthcare

NASDAQ:OGI · NASDAQ Global Select

Market Cap $152.04M Beta 1.84 P/E (TTM) -7.8

$1.06 -1.85%

-$0.02 today

52W Low $1.04High $2.24

Vol 0.25M · Avg 0.67M

EPS (TTM)-$0.19

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-24.29%

Period High

$2.11

Period Low

$1.04

Latest

$1.06

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Electromed, Inc.

AMEX:ELMD

$307.52M

Cartesian Therapeutics, Inc.

NASDAQ:RNAC

$279.42M

Orchestra BioMed Holdings, Inc.

NASDAQ:OBIO

$245.51M

Lifecore Biomedical, Inc.

NASDAQ:LFCR

$211.55M

Inventiva S.A.

NASDAQ:IVA

$200.13M

InfuSystem Holdings, Inc.

AMEX:INFU

$184.46M

Journey Medical Corporation

NASDAQ:DERM

$174.49M

Aurora Cannabis Inc.

NASDAQ:ACB

$172.40M

Solana Company

NASDAQ:HSDT

$89.92M

China SXT Pharmaceuticals, Inc.

SXTC

$1.99M

What is the latest OGI filing?

The latest filing shown is 6-K dated May 12, 2026.

How many recent filings does OGI have?

Intrinsic Alpha currently shows 20 recent filings for OGI.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.